General Information of Drug (ID: DME7PBN)

Drug Name
mRNA-3704 Drug Info
Indication
Disease Entry ICD 11 Status REF
Methylmalonic acidemia 5C50.E0 Phase 1/2 [1]
Cross-matching ID
TTD Drug ID
DME7PBN

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Approved Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydroxocobalamin DMGKV9D Cerebral edema 8D60.1 Approved [3]

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Methylmalonyl-CoA mutase (MMUT) TTCQ21Y MUTA_HUMAN Replacement [2]

References

1 ClinicalTrials.gov (NCT03810690) Open Label Study of mRNA-3704 in Patients With Isolated Methylmalonic Acidemia. U.S. National Institutes of Health.
2 Clinical pipeline report, company report or official report of Moderna Therapeutics.
3 Vitamin B12. Nippon Rinsho. 1999 Oct;57(10):2205-10.